CAM
DPLO

Capstone Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Capstone Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$362K Buy
24,430
+120
+0.5% +$2K 0.01% 1120
2017
Q1 		$388K Sell
24,310
-770
-3% -$11.1K 0.01% 1081
2016
Q4 		$316K Buy
25,080
+12,530
+100% +$233K 0.01% 1277
2016
Q3 		$352K Buy
12,550
+1,640
+15% +$55K 0.01% 1211
2016
Q2 		$382K Buy
+10,910
New +$343K 0.01% 1142

Other funds holding DPLO

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capstone Asset Management's DPLO Position: Q2 2017 in Review

Capstone Asset Management increased its DIPLOMAT PHARMACY, INC. (DPLO) stake by 0.49% in Q2 2017, buying an estimated $2K and bringing the position to 24,430 shares worth $362K. The position accounts for 0.01% of the portfolio, ranked #1120.

Capstone Asset Management first reported a position in DPLO in Q2 2016 and has held it in 5 quarters since. The position peaked at $388K in Q1 2017. 175 funds tracked by Wall St. Rank hold DPLO as of Q2 2017.

  • Capstone Asset Management held 24,430 shares of DIPLOMAT PHARMACY, INC. worth $362K as of Q2 2017.
  • Capstone Asset Management bought 120 DIPLOMAT PHARMACY, INC. shares in Q2 2017, an estimated $2K.
  • DIPLOMAT PHARMACY, INC. made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1120 holding.
  • Capstone Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and has held it in 5 quarters since.
  • Capstone Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $388K in Q1 2017.
  • 175 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.